DURECT Corp
NASDAQ:DRRX
$0.80
-$0.02
(-2.44%)
Quote as of 3:28 PM EST on 02/10/12
Related Resources
DRRX
vs. S&P 500
|
$0.80
-$0.02
(-2.44%)
|
|
| Today's Open | $0.81 |
|---|---|
| Previous Close | $0.82 |
| Daily Range | $0.80 - $0.85 |
| 52-Week Range | $0.72 - $3.77 |
| Market Cap | $69.96M |
| P/E Ratio | -3.28 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 88,278 |
| Average Daily Volume | 559,513 |
| Current FY EPS | -$0.27 |
DRRX Information
| Description |
|---|
| The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Durect Investors Feel the Pain
1/6/2012 by DailyFinance
US Stock Futures: HOT STOCKS TO WATCH
1/6/2012 by Smart Money
US Stock Futures: HOT STOCKS TO WATCH
1/6/2012 by Smart Money
11/18/2011 by DailyFinance
10/6/2011 by DailyFinance
9/19/2011 by DailyFinance
8/29/2011 by DailyFinance
Pain Therapeutics: FDA Says Pain Killer Had Inconsistent Results
6/27/2011 by Smart Money
Oracle, Micron Tech and Pfizer light up StockTwits
6/24/2011 by CNN Money
Pain Therapeutics, Durect Shares Plunge on Pain Drug Rejection
6/24/2011 by Minyanville
